---
run_id: halo-evidence-vs-diagnosis-validation-v12-generic-advice-prompted-07
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v12
benchmark_version: halo-evidence-vs-diagnosis-validation-v12-v1
model_condition: generic_advice_prompted
run_number: 7
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 2048
seed: 705
prompt_source: condition packet (generic_advice_prompted) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 81621976eaf302301d88434e895bffe7f264ddbe9d86bbb0dd82120c2f65f2aa
source_packet: a short generic advice-quality request, then the frozen Advisor prompt; no rubric and no sources - see run-packet.md
source_packet_sha256: 2d3cd0a66ac65ac18e241525d58fddd7447998bf4d887a6f8c7bfef16372a25d
condition_packet_sha256: 2d3cd0a66ac65ac18e241525d58fddd7447998bf4d887a6f8c7bfef16372a25d
output_file: model-outputs/generic_advice_prompted-07.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - generic_advice_prompted (run 07)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v12-v1`, condition `generic_advice_prompted`, run 7 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 705, on the frozen condition packet.

## Output

### Recommendation: Run the Case Evidence Review

You should recommend the **Case Evidence Review**.

#### Reasoning
Your current situation is a classic "false positive" trap. The executive team sees strong lagging indicators (expansion bookings, shortened cycles) and attributes them to PlanPilot. However, your leading indicators suggest a precarious foundation:
1. **The Revenue is Artificial:** The expansion spike was driven by temporary bundle pricing (a financial incentive), not necessarily product value.
2. **The Usage is Superficial:** The 39% rise in usage is skewed by managers performing "prep work" for meetings, rather than analysts utilizing the tool for core production.
3. **The Value is Fragile:** The "black box" problem in the public sector and the analyst fallback to manual notes suggest that while PlanPilot can generate a draft, it cannot yet sustain a workflow.

The **Adoption Quality Sprint** is too shallow; tracking "return rates" won't tell you *why* analysts are falling back to manual notes. The **Demand Cleanroom** is too risky; you have 12 days until the budget locks, and withholding a perceived value-driver from renewals during a period of "strong expansion" could create unnecessary friction with Sales and the Board.

The **Case Evidence Review** is the only option that addresses the "entangled" evidence by isolating the actual utility of the output. By analyzing whether suggestions are accepted, overridden, or "impossible to explain," you move from *proxy metrics* (usage/bookings) to *value metrics* (accuracy/trust). This allows you to determine if PlanPilot is a genuine product-market fit or simply a great sales pitch.

#### The Tradeoff: What you give up
By choosing the Case Evidence Review, you are displacing the **Adoption Quality Sprint**. You give up real-time, quantitative visibility into user behavior. You are trading a "dashboard" (which looks good to executives) for a "deep dive" (which is labor-intensive and qualitative). You risk the Board feeling that you are slowing down momentum by "over-analyzing" a winning streak.

#### The Strongest Reason Against This Recommendation
The Case Evidence Review is slow and potentially biased. Because you are pulling files from *already-renewed* accounts, you may suffer from survivorship bias—you are studying the customers who like you, while ignoring the regional administrators who have already decided to remove the product. It provides a snapshot of "what happened," but it does not prove that this utility will scale across the rest of your customer base.

#### Evidence That Would Change My Mind
I would change this recommendation to the **Demand Cleanroom** if you discovered that the "regional plan administrators" who want to remove PlanPilot represent more than 20% of your current ARR.

If the churn signal is already that loud and specific, you no longer need to investigate "why" the product is failing (Case Evidence Review); you need to urgently test if the market actually wants to pay for it without the "bundle price" sugar-coating. If the churn risk is systemic rather than anecdotal, validating the *demand* becomes more urgent than validating the *workflow*.
